ATE435646T1 - Perfluorkohlenstoffe als entzündungshemmendes mittel - Google Patents

Perfluorkohlenstoffe als entzündungshemmendes mittel

Info

Publication number
ATE435646T1
ATE435646T1 AT94929390T AT94929390T ATE435646T1 AT E435646 T1 ATE435646 T1 AT E435646T1 AT 94929390 T AT94929390 T AT 94929390T AT 94929390 T AT94929390 T AT 94929390T AT E435646 T1 ATE435646 T1 AT E435646T1
Authority
AT
Austria
Prior art keywords
perfluorocarbons
inflammatory agent
tissue
reducing
inflammation
Prior art date
Application number
AT94929390T
Other languages
English (en)
Inventor
Bradley Fuhrman
Stephen Flaim
Lynn Hernan
Frances Nesti
Michele Cecile Papo
David Steinhorn
Original Assignee
Univ New York State Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ New York State Res Found filed Critical Univ New York State Res Found
Application granted granted Critical
Publication of ATE435646T1 publication Critical patent/ATE435646T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/02—Halogenated hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Pulmonology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT94929390T 1993-09-29 1994-09-29 Perfluorkohlenstoffe als entzündungshemmendes mittel ATE435646T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/128,811 US5470885A (en) 1993-09-29 1993-09-29 Fluorocarbons as anti-inflammatory agents
PCT/US1994/011092 WO1995008985A1 (en) 1993-09-29 1994-09-29 Perfluorocarbons as anti-inflammatory agents

Publications (1)

Publication Number Publication Date
ATE435646T1 true ATE435646T1 (de) 2009-07-15

Family

ID=22437089

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94929390T ATE435646T1 (de) 1993-09-29 1994-09-29 Perfluorkohlenstoffe als entzündungshemmendes mittel

Country Status (8)

Country Link
US (2) US5470885A (de)
EP (1) EP0738142B1 (de)
JP (1) JPH09503211A (de)
AT (1) ATE435646T1 (de)
AU (1) AU691837B2 (de)
CA (1) CA2172601A1 (de)
DE (1) DE69435215D1 (de)
WO (1) WO1995008985A1 (de)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992019232A1 (en) * 1991-05-03 1992-11-12 Alliance Pharmaceutical Corp. Partial liquid breathing of fluorocarbons
US5470885A (en) * 1993-09-29 1995-11-28 The Research Foundation Of The State University Of New York Fluorocarbons as anti-inflammatory agents
US5861175A (en) * 1996-03-15 1999-01-19 Alliance Pharmaceutical Corp. Use of fluorocarbons for diagnosis and treatment of articular disorders
WO1998016210A1 (en) * 1996-10-15 1998-04-23 Sonus Pharmaceuticals, Inc. Fluorocarbon-containing agents for pulmonary lavage and drug delivery
SE507617C2 (sv) * 1996-12-20 1998-06-29 Siemens Elema Ab Anordning avsedd att användas vid ett behandlingssystem för respiratorvård med vätska
US20060025348A1 (en) * 1997-05-28 2006-02-02 Pilon Aprile L Methods and compositions for the treatment of fibrotic conditions & impaired lung function & to enhance lymphocyte production
US20060281681A1 (en) * 1997-05-28 2006-12-14 Pilon Aprile L Methods and compositions for the reduction of neutrophil influx and for the treatment of bronchpulmonary dysplasia, respiratory distress syndrome, chronic lung disease, pulmonary fibrosis, asthma and chronic obstructive pulmonary disease
US6255281B1 (en) * 1997-05-28 2001-07-03 Claragen, Inc. And U.S. Government Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US6309623B1 (en) 1997-09-29 2001-10-30 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in metered dose inhalers
US6565885B1 (en) 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
US6433040B1 (en) 1997-09-29 2002-08-13 Inhale Therapeutic Systems, Inc. Stabilized bioactive preparations and methods of use
US6946117B1 (en) 1997-09-29 2005-09-20 Nektar Therapeutics Stabilized preparations for use in nebulizers
DE19823606C2 (de) * 1998-05-27 2002-02-28 Draeger Medical Ag Verwendung von Perfluorcarbone in einem Atemgasgemisch sowie die Vorrichtung
US6894079B1 (en) 1998-12-01 2005-05-17 Alexandre T. Rotta Method for reducing free-radical induced injury
ES2160534B1 (es) * 1999-12-30 2002-04-16 Vita Invest Sa Nuevos esteres derivados de (rr,ss)-2-hidroxibenzoato de 3-(2-dimetilaminometil-1-hidroxiciclohexil) fenilo.
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
US8404217B2 (en) 2000-05-10 2013-03-26 Novartis Ag Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
EP1280520B2 (de) 2000-05-10 2018-03-21 Novartis AG Pulver auf basis von phospholipiden zur wirkstoffverabreichung
US6235796B1 (en) * 2000-06-26 2001-05-22 Sarfaraz K. Niazi Use of fluorocarbons for the prevention of surgical adhesions
EP1554572B1 (de) 2001-07-25 2009-10-14 Raptor Pharmaceutical Inc. Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke
ATE508735T1 (de) 2001-12-19 2011-05-15 Novartis Ag Pulmonale verabreichung von aminoglykosiden
US6899890B2 (en) * 2002-03-20 2005-05-31 Kv Pharmaceutical Company Bioadhesive drug delivery system
JP4079257B2 (ja) * 2002-10-01 2008-04-23 株式会社リコー 静電荷像現像用トナー
US20050118108A1 (en) * 2003-11-28 2005-06-02 Cowan Ada S. Pulmonary delivery of a liquid medicament aerosol
JP2008539047A (ja) 2005-04-28 2008-11-13 プロテウス バイオメディカル インコーポレイテッド ファーマインフォーマティックスシステム
US7566743B2 (en) * 2005-11-18 2009-07-28 Mark Glazman System and method for medical treatment
CA2633099C (en) * 2005-12-21 2015-04-21 Uti Limited Partnership Treatment of respiratory diseases
KR20090071598A (ko) 2006-09-18 2009-07-01 랩터 파마슈티컬 인코포레이티드 수용체 결합 단백질(ｒａｐ)-접합체 투여에 의한 간 질환의 치료
AU2009246543B2 (en) 2008-05-13 2015-08-06 Clarassance, Inc. Recombinant human CC10 and compositions thereof for use in the treatment of nasal rhinitis
PT2398500T (pt) 2009-02-20 2019-06-14 2 Bbb Medicines B V Sistema de entrega de medicamentos à base de glutationas
CN102458374A (zh) 2009-05-06 2012-05-16 实验室护肤股份有限公司 包含活性剂-磷酸钙颗粒复合物的皮肤递送组合物及其使用方法
US9168285B2 (en) 2009-10-15 2015-10-27 Therabron Therapeutics, Inc. Recombinant human CC10 protein for treatment of influenza and ebola
KR101597391B1 (ko) 2009-10-15 2016-02-24 클라라산스, 인크. 인플루엔자 치료용 재조합 사람 ｃｃ10 단백질
JP2011246396A (ja) * 2010-05-27 2011-12-08 Shiseido Co Ltd 血流促進剤および外用剤
EP2587917A4 (de) * 2010-07-01 2015-05-06 Mtm Res Llc Fluorchemische antifibroblasten-emulsionstherapien
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
US20250041332A1 (en) * 2021-09-13 2025-02-06 The Board Of Regents Of The University Of Texas System Systemic injection of superheated perfluorocarbon emulsion to improve ventilation and reduce ventilator-induced lung injury

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4044121A (en) * 1976-03-11 1977-08-23 Minnesota Mining And Manufacturing Company Hair spray containing fluorocarbon compounds as additives
US4680173A (en) * 1977-04-28 1987-07-14 Norman D. Burger Aerosol dispensing system
US4490351A (en) * 1982-03-15 1984-12-25 Children's Hospital Medical Center Methods of treating disorders of an eye with liquid perfluorocarbons
US4543202A (en) * 1984-03-23 1985-09-24 E. I. Du Pont De Nemours And Company Aerosol propellant compositions
US5192528A (en) * 1985-05-22 1993-03-09 Liposome Technology, Inc. Corticosteroid inhalation treatment method
US5284645A (en) * 1987-08-05 1994-02-08 Alliance Pharmaceutical Corp. Fluorocarbon emulsions containing amino acid based anti-inflamatory agents and buffer systems
US4927623A (en) * 1986-01-14 1990-05-22 Alliance Pharmaceutical Corp. Dissolution of gas in a fluorocarbon liquid
US4987154A (en) * 1986-01-14 1991-01-22 Alliance Pharmaceutical Corp. Biocompatible, stable and concentrated fluorocarbon emulsions for contrast enhancement and oxygen transport in internal animal use
US4865836A (en) * 1986-01-14 1989-09-12 Fluoromed Pharmaceutical, Inc. Brominated perfluorocarbon emulsions for internal animal use for contrast enhancement and oxygen transport
EP0324802A4 (en) * 1986-09-19 1991-07-24 Chemex Pharmaceuticals, Inc. Method for the treatment of body tissues and the administration of drugs thereto
US4897262A (en) * 1988-03-22 1990-01-30 Playtex Jhirmack, Inc. Non-aerosol hair spray composition
US5028428A (en) * 1988-08-09 1991-07-02 Estee Lauder Inc. Anti-irritant and desensitizing compositions and methods of their use
US5225183A (en) * 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
US5213570A (en) * 1990-12-14 1993-05-25 Mallinckrodt Medical, Inc. System and method for oxygenation of the pericardium
ES2181673T3 (es) * 1991-05-01 2003-03-01 Jackson H M Found Military Med Procedimiento de tratamiento de las enfermedades respiratorias infecciosas.
US5437272A (en) * 1991-05-01 1995-08-01 Alliance Pharmaceutical Corp. Perfluorocarbon associated gas exchange
WO1992019232A1 (en) * 1991-05-03 1992-11-12 Alliance Pharmaceutical Corp. Partial liquid breathing of fluorocarbons
US5470885A (en) * 1993-09-29 1995-11-28 The Research Foundation Of The State University Of New York Fluorocarbons as anti-inflammatory agents

Also Published As

Publication number Publication date
EP0738142A4 (de) 1997-07-16
DE69435215D1 (de) 2009-08-20
EP0738142B1 (de) 2009-07-08
CA2172601A1 (en) 1995-04-06
AU7846994A (en) 1995-04-18
AU691837B2 (en) 1998-05-28
EP0738142A1 (de) 1996-10-23
US5470885A (en) 1995-11-28
JPH09503211A (ja) 1997-03-31
WO1995008985A1 (en) 1995-04-06
US5733939A (en) 1998-03-31

Similar Documents

Publication Publication Date Title
DE69435215D1 (de) Perfluorkohlenstoffe als entzündungshemmendes Mittel
YU47204B (sh) Derivati didehidro-vitamina d3
EA199800667A1 (ru) Новые фенантридины
ES2173115T3 (es) Composiciones de limpieza en microemulsion y emulsion.
DK0782855T3 (da) Nimesulid til ekstern anvendelse
ES2162951T3 (es) Estabilizacion de composiciones de prostaglandina.
NO954441D0 (no) Tricyklopolyazamakrocyklofosfonsyrer, komplekser og derivater derav for anvendelse som kontrastmidler
NO975716L (no) Imidazolforbindelser
TR199701544T1 (xx) Yeni dolastatin t�revleri,bunlar�n haz�rlanmas� ve kullan�lmas�.
EP1048659A4 (de) Retinoid-rezeptor-antagonisten
ES2051461T3 (es) Medios de contraste.
FI911207A0 (fi) Menetelmä uuden terapeuttisesti käyttökelpoisen retinoidin valmistamiseksi
FR2713444B1 (fr) Composition liquide désinfectante et ses utilisations.
DE69414194D1 (de) Aminosäurederivate und ihre Verwendung als Enkephalinase-Inhibitoren
DK0821588T3 (da) Levobupivacain og anvendelse heraf som et anæstetikum til gravide kvinder
ES2107852T3 (es) Procedimiento para la obtencion de 1,4-butanodiol.
IT1252603B (it) 2,4-diamino-6 piperidino pirimidina-3 ossido topico sul glande nel trattamento delle impotenze erettili
AR245433A1 (es) Purificacion de 2,2-dicloro-1,1,1-trifluoretano.
ES2181787T3 (es) Derivados de la 3h-2,3-benzodiazepina sustituidos en posicion 3, y su su utilizacion como medicamentos
DK0453603T3 (da) Piroxicamholdige farmaceutiske præparater til topisk anvendelse
ES2152315T3 (es) Xamoneline tartrato.
FR2569569B1 (fr) Exerciseur destine notamment au travail du grand ecart.
ES2143125T3 (es) Uso de copolimeros anfifilicos que contienen un monomero fluorado para impartir impermeabilidad al cuero.
IT1271075B (it) Miscele ternarie di solventi, e loro uso per la rimozione di sostanze oleose
IT1250410B (it) Composti steroidei attivi sul sistema cardiovascolare

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties